Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albee Messing

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
ASN Neuro|October 10, 2013
Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregationMei-Hsuan Chen, Tracy L Hagemann, Roy A Quinlan, et al.
Nature Communications|November 27, 2015
Nitric oxide mediates glial-induced neurodegeneration in Alexander diseaseLiqun Wang, Tracy L Hagemann, Hermann Kalwa, et al.
Behavioural Brain Research|March 23, 2026
Progressive gait and motor deficits in a rat model of Alexander diseaseRobert F Berman, Matthew R Matson, Angelica M Bachman, et al.
Cells|April 13, 2023
STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander DiseaseTracy L Hagemann, Sierra Coyne, Alder Levin, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 1, 2024
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander diseaseNicholas J Ashton, Guglielmo Di Molfetta, Kübra Tan, et al.
Molecular and Cellular Neurosciences|October 24, 2006
The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microgliaUlrike Pannasch, Katrin Färber, Christiane Nolte, et al.
The American Journal of Pathology|December 7, 2007
Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic proteinWei Zou, Byung Oh Kim, Betty Y Zhou, et al.
Plos One|January 18, 2024
Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's diseaseStephen C Gammie, Albee Messing, Mason A Hill, et al.
BMC Biology|October 11, 2007
Sleep in Kcna2 knockout miceChristopher L Douglas, Vladyslav Vyazovskiy, Teresa Southard, et al.
Molecular Biology of the Cell|November 1, 2016
The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAPNi-Hsuan Lin, Yu-Shan Huang, Puneet Opal, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
ASN Neuro|October 10, 2013
Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregationMei-Hsuan Chen, Tracy L Hagemann, Roy A Quinlan, et al.
Nature Communications|November 27, 2015
Nitric oxide mediates glial-induced neurodegeneration in Alexander diseaseLiqun Wang, Tracy L Hagemann, Hermann Kalwa, et al.
Behavioural Brain Research|March 23, 2026
Progressive gait and motor deficits in a rat model of Alexander diseaseRobert F Berman, Matthew R Matson, Angelica M Bachman, et al.
Cells|April 13, 2023
STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander DiseaseTracy L Hagemann, Sierra Coyne, Alder Levin, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 1, 2024
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander diseaseNicholas J Ashton, Guglielmo Di Molfetta, Kübra Tan, et al.
Molecular and Cellular Neurosciences|October 24, 2006
The potassium channels Kv1.5 and Kv1.3 modulate distinct functions of microgliaUlrike Pannasch, Katrin Färber, Christiane Nolte, et al.
The American Journal of Pathology|December 7, 2007
Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic proteinWei Zou, Byung Oh Kim, Betty Y Zhou, et al.
Plos One|January 18, 2024
Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's diseaseStephen C Gammie, Albee Messing, Mason A Hill, et al.
BMC Biology|October 11, 2007
Sleep in Kcna2 knockout miceChristopher L Douglas, Vladyslav Vyazovskiy, Teresa Southard, et al.
Molecular Biology of the Cell|November 1, 2016
The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAPNi-Hsuan Lin, Yu-Shan Huang, Puneet Opal, et al.
Pageof 11